SREBF2 and diffuse large B-cell lymphoma: Compared to normal lymphocyte cell lines, the expression of key regulatory factors for de novo cholesterol synthesis, such as SREBP2 and the rate-limiting enzyme HMGCR, was significantly higher in DLBCL cell lines.